Association between high-density lipoprotein cholesterol to apolipoprotein A ratio and diabetic retinopathy: A cross-sectional study
- PMID: 37127002
- DOI: 10.1016/j.jdiacomp.2023.108471
Association between high-density lipoprotein cholesterol to apolipoprotein A ratio and diabetic retinopathy: A cross-sectional study
Abstract
Aims: Our study is aimed to investigate the relationship between high-density lipoprotein cholesterol to apolipoprotein A ratio (HDL-C/ApoA) and diabetic retinopathy (DR) in subjects with type 2 diabetes mellitus (T2DM).
Methods: We retrospect the consecutive medical files of 1058 subjects with T2DM and recorded their clinical information and laboratory findings. Subjects with T2DM were divided into DR group (n = 522) and non-DR group (n = 536). We compared the lipids values of the two groups. Meanwhile we also observed the prevalence of DR at different HDL-C/ApoA levels. Binary logistic regression was used to correct confounding factors. Smooth curve fitting model and subgroup analysis were used to determine the correlation, non-linear relationship and threshold effect between HDL/ApoA and DR.
Results: HDL-C/ApoA value of DR group was significantly higher than non-DR group (0.88 ± 0.17 vs 0.84 ± 0.13, P < 0.05). The prevalence of DR significantly increased as HDL-C/ApoA level increased. There was association between HDL/ApoA levels and DR in the adjusted models (OR 1.55, 95%CI 0.60 to 4.02). After full adjustments for other relevant clinical covariates, patients with HDL/ApoA values in quartile 3 (Q3) had 1.50 times (95 % CI 1.00 to 2.17) and in Q4 had 2.39 times (95%CI 1.65 to 3.47) as high as the risk of DR compared with patients in Q1. HDL/ApoA showed a non-linear relationship with DR, with an inflection point value of 0.759. When HDL/ApoA>0.759, HDL/ApoA was significantly positively associated with DR (HR = 26.508, 95 % CI 7.623-92.174; P < 0.0001). Compared to patients with age < 60, HDL/ApoA was obviously associated with DR when age ≥ 60 (OR = 38.05, 95 % CI 8.06-179.69; P < 0.001).
Conclusions: HDL-C/ApoA was found to be associated with the incidence of DR in patients with T2DM. After adjusting potential related factors HDL-C/ApoA OR value was 1.55 (95%CI 0.60 to 4.02). A non-linear association between HDL/ApoA and DR was observed in T2DM. Subgroup analysis showed that age could alter the relationship between HDL/ApoA and DR.
Keywords: Diabetic retinopathy; HDL-C/ApoA; Lipids; Type 2 diabetes mellitus.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no conficts of interest.
Similar articles
-
Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.Front Endocrinol (Lausanne). 2022 Jul 22;13:915575. doi: 10.3389/fendo.2022.915575. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35937834 Free PMC article.
-
C-reactive protein to high-density lipoprotein cholesterol ratio: an independent risk factor for diabetic retinopathy in type 2 diabetes patients.Front Nutr. 2025 Mar 4;12:1537707. doi: 10.3389/fnut.2025.1537707. eCollection 2025. Front Nutr. 2025. PMID: 40104822 Free PMC article.
-
The non-linear association between remnant cholesterol/high-density lipoprotein cholesterol ratio and diabetic retinopathy: a cross-sectional study in type 2 diabetic patients.Diabetol Metab Syndr. 2025 May 26;17(1):172. doi: 10.1186/s13098-025-01719-3. Diabetol Metab Syndr. 2025. PMID: 40414909 Free PMC article.
-
Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.Cardiovasc Diabetol. 2016 Sep 13;15(1):132. doi: 10.1186/s12933-016-0450-1. Cardiovasc Diabetol. 2016. PMID: 27620179 Free PMC article.
-
Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer's Disease: Systematic Review and Meta-Analysis.Diagnostics (Basel). 2021 May 28;11(6):984. doi: 10.3390/diagnostics11060984. Diagnostics (Basel). 2021. PMID: 34071695 Free PMC article. Review.
Cited by
-
Lipids, Apolipoproteins, Lipid-Lowering Drugs, and the Risk of Cerebral Small Vessel Disease: A Mendelian Randomization Study.J Am Heart Assoc. 2024 Aug 20;13(16):e032409. doi: 10.1161/JAHA.123.032409. Epub 2024 Aug 19. J Am Heart Assoc. 2024. PMID: 39158561 Free PMC article.
-
Increased high-density lipoprotein cholesterol in patients with type 2 diabetes and its correlates: a cross-sectional, matched case-control survey.Eur J Med Res. 2024 Jul 2;29(1):355. doi: 10.1186/s40001-024-01950-0. Eur J Med Res. 2024. PMID: 38956709 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical